In Australia, data from 2023 describes 15 985 primary MBScompleted in the same year and the incidence of these procedures continues to rise in Australia [5, 6]
Eli Lillys acquisition of Versanis Bio and integration of bimagrumab into its portfolio highlight its commitment to leading the market in innovative weight loss therapies
During some of the landmark clinical trials of GLP-1 drugs that demonstrated reductions in body weight, researchers heard anecdotal reports from participants about changes in habits
Patients who increase their tirzepatide dose more slowly often experience milder and shorter-lived GI symptoms compared to rapid dose increases
If prescribed, compounded tirzepatide ships discreetly to your home - nothing is closer than your door
The fight against tobacco, certainly in our lifetime, has been the great public health success